EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Inflammageing, a targetable pathway for preventing cardiovascular diseases

Juan Francisco Aranda, Cristina M Ramírez iD, María Mittelbrunn

Cardiovascular Research · 28.08.2025 · 121 (10) · 1537-1550

DOI: 10.1093/cvr/cvae240 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Research, online erschienen am 12.11.2024. Verfasst von Juan Francisco Aranda und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Physiology and Microbiology, Faculty of Biology, Complutense University of Madrid, C. de José Antonio Novais, 12, 28040 Madri…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Inflammation, Inflammation Mediators, Aging. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Mittelbrunn lab by the European Regional Development Fund, European Commission, European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammageing, characterized by persistent chronic inflammation in older adults, has emerged as a critical factor linked to age-related diseases, such as cardiovascular diseases (CVDs), metabolic disorders, and cognitive decline, which collectively contribute to the leading causes of death globally. Elevated levels of cytokines, chemokines, and other inflammatory mediators characterize inflammageing and serve as indicators of biological age. Among the causes of inflammageing, deterioration of the immune system, mitochondrial dysfunction, dysbiosis, accumulation of DAMPs, together with genetic or epigenetic factors, contribute to inflammageing not only in CVD but also in other age-related conditions. This review examines the causes and consequences of inflammageing, particularly its implications for atherosclerosis and heart failure with preserved ejection fraction and explores potential strategies to mitigate it in the onset of CVD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesInflammationInflammation MediatorsAgingInflammasomesAnti-Inflammatory AgentsHumansAnimalsSignal TransductionAge Factors

Stichwörter der Autor:innen

AgeingAtherosclerosisHFpEFHeart failureInflammation

Substanzen

Inflammation MediatorsInflammasomesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Genetics, Physiology and Microbiology, Faculty of Biology, Complutense University of Madrid, C. de José Antonio Novais, 12, 28040 Madrid, Spain.
  • IMDEA Research Institute of Food and Health Sciences, Carretera de Cantoblanco number 8, 28049 Madrid, Spain.
  • Tissue and Organ Homeostais Program, Centro de Biología Molecular Severo Ochoa (CBM), Consejo Superior de Investigaciones Científicas (CSIC)-Universidad Autónoma de Madrid (UAM), Calle Nicolás Cabrera 1, 28049 Madrid, S…

ORCID-Profile: Cristina M Ramírez

Förderung

  • Mittelbrunn lab by the European Regional Development Fund
  • European Commission
  • European Research Council
  • European Union

Zitieren

APA

Aranda, J. F., Ramírez, C. M., & Mittelbrunn, M. (2025). Inflammageing, a targetable pathway for preventing cardiovascular diseases. Cardiovascular Research, 121(10), 1537-1550. https://doi.org/10.1093/cvr/cvae240

Vancouver

Aranda JF, Ramírez CM, Mittelbrunn M. Inflammageing, a targetable pathway for preventing cardiovascular diseases. Cardiovascular Research. 2025;121(10):1537-1550. doi:10.1093/cvr/cvae240

BibTeX
@article{Aranda2025,
  author = {Aranda, Juan Francisco and Ramírez, Cristina M and Mittelbrunn, María},
  title = {Inflammageing, a targetable pathway for preventing cardiovascular diseases},
  journal = {Cardiovascular Research},
  year = {2025},
  volume = {121},
  number = {10},
  pages = {1537--1550},
  doi = {10.1093/cvr/cvae240}
}
Kostenlos starten →